Skip to main content


Growth differentiation factor-15 and prediction of cancer-associated thrombosis and mortality

In collaboration with the Medical University of Vienna and the University Hospital of Zurich, members of the Center for Molecular Cardiology have studied the role of growth differentiation factor-15 (GDF-15) for its predictive utility for adverse events in patients with cancer.

Access the full article

Low-density lipoprotein electronegativity and risk of death after acute coronary syndromes: A case-cohort analysis

Low-density lipoprotein (LDL)-cholesterol (LDL-C) promotes atherosclerotic cardiovascular disease (ASCVD), with changes in LDL electronegativity modulating its pro-atherogenic/pro-thrombotic effects.

Read full article (Atherosclerosis 376 (2023) 43–52)



Occlusion of the infarct-related coronary artery presenting as acute coronary syndrome with and without ST-elevation: impact of inflammation and outcomes in a real-world prospective cohort

Identifying the IRA in patients with ACSs has profound diagnostic, therapeutic, and prognostic implications

Read full article (Eur Heart J Qual Care Clin Outcomes (2023) 0, 1–11)


Wein, Schokolade und Kaffee: Wie gesund sind sie?

Das Leben besteht aus mehr als nur Arbeit, auch für engagierte Kardiolog:innen, Gastroenterolog:innen und Ernährungsmediziner:innen. So geniessen wir alle – und auch die Patient:innen – gerne Wein, Getränke, Süssigkeiten und Kaffee, allein oder in Gesellschaft. Sind das verbotene Freuden oder schützen sie gar vor Krankheit und Tod?

Lesen Sie den ganzen Artikel (gastroMAG, N°2, Mai 2023)

Sex and cardiovascular disease

For many years, cardiovascular disease was considered a male disease. Consequently, common data of registries, clinical trials and the like, were all reported for the entire patient population and only until recently has it become mandatory to report data on males and females separately.

Read full article (Cardiovasc Med 2023;26(3):67)

Initial systolic blood pressure associates with systemic inflammation, myocardial injury, and outcomes in patients with acute coronary syndromes

Cardiovascular (CV) diseases remain the leading cause of death globally, of which the majority are due to chronic and acute coronary syndromes (ACS).

Read full article (European Heart Journal: Acute Cardiovascular Care (2023) 00, 1–14)


Professor Thomas Lüscher awarded Honorary Membership

Professor Thomas Lüscher, MD,  FRCP, FESC: awarded Honorary Membership of the Hungarian Society of Cardiology Balatonfüred, Hungary, May 11, 2023

Takotsubo syndrome: getting closer to its causes

Takotsubo syndrome (TTS) accounts for between 1 and 4% of cases presenting clinically as an acute coronary syndrome. It typically presents as a transient cardiac phenotype of left ventricular dysfunction with spontaneous recovery.

Read full article (Cardiovascular Research (2023) 00, 1–15)

The Future of Cardiology

An den Grand Rounds des Royal Brompton Hospital in London sprach Prof. Thomas Lüscher, London/Zürich, über die Errungenschaften der Kardiologie in den letzten Jahrzehnten und über ihre Zukunft.

Lesen Sie den ganzen Artikel (herz+gefäss _ 02 _ 2023)

Clinical and Prognostic Relevance of Cardiac Wasting in Patients With Advanced Cancer

In advanced cancer, cachexia is frequently observed in 30% to 80% of patients, depending on the cancer type, stage, and comorbidities.